Collaboration

NIVIRON operates as both a technological and business partner, combining scientific expertise, platform capabilities, and an industry-driven approach to creating new technologies and bringing them to market.

We are open to building long-term strategic partnerships with commercial and non-commercial organizations in the field of gene therapy to accelerate the achievement of shared goals.

Collaboration Formats

  • Long-term scientific and technological partnerships
  • Joint R&D programs
  • Technology licensing
  • Creation of joint ventures

What we can offer our partners

What we can offer our partners

  • Intellectual and computational infrastructure (R&D automation)
  • Laboratory infrastructure
  • Support in moving from an idea to technologically mature solutions
  • Support throughout the process of bringing technologies to market

Get in touch

If you are developing technologies in the field of gene therapy or looking for partners for collaborative research, feel free to reach out.

Tell Us About Yourself

By submitting this form, you agree that we may contact you regarding your request.

Privacy Policy

© 2025 Inc, Niviron,
All Rights Reserved.

Прокрутить вверх

Shapovalov Nikita

CEO

An entrepreneur with over 11 years of experience in creating and managing technology projects in biotechnology, digital health, and artificial intelligence.

 

Specializes in:
launching and developing projects at the preclinical stage,
IP licensing,

  • collaboration with universities and research institutions,
  • building R&D infrastructure,
  • securing funding,
  • preparing for grant and venture rounds.

Possesses hands-on experience in:

  • team formation,
  • market entry strategy development and implementation,
  • product packaging,
  • regulatory engagement.

Additional expertise includes:

  • AI and process automation in medicine,
  • development of digital solutions (mobile applications, patient portals, chatbots, mini apps),
  • strategic marketing and systematic sales in highly competitive niches.

Has access to a strong network of experts, investors, and contractors across the EU and US.

Capable of building projects from scratch to investment readiness, including comprehensive development of business models, scientific tracks, and market strategies.